참고문헌 (24)

1. American Journal of Hospital Pharmacy Lipman AG S7 47 58 1990 

2. Ross, Fraser B, Smith, Maree T. The intrinsic antinociceptive effects of oxycodone appear to be κ-opioid receptor mediated. Pain, vol.73, no.2, 151-157.

   상세보기

3. Ross, F.B., Wallis, S.C., Smith, M.T.. Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats. Pain, vol.84, no.2, 421-428.

   상세보기

4. Coyle, N., Adelhardt, J., Foley, K.M., Portenoy, R.K.. Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of life. Journal of pain and symptom management, vol.5, no.2, 83-93.

   상세보기

5. Fainsinger, Robin, Miller, Melvin J., Bruera, Eduardo, Hanson, John, Maceachern, Tara. Symptom Control during the Last Week of Life on a Palliative Care Unit. Journal of palliative care, vol.7, no.1, 5-11.

   상세보기

6. Management of Cancer Pain US Department of Health and Human Services 1994 

7. Journal of Pain and Symptom Management Mercadante S 1999 

8. Portenoy, Russell K, Lesage, Pauline. Management of cancer pain. The Lancet, vol.353, no.9165, 1695-1700.

   상세보기

9. Heiskanen, Tarja, Kalso, Eija. Controlled-release oxycodone and morphine in cancer related pain. Pain, vol.73, no.1, 37-45.

   상세보기

10. Portenoy, R.K., Hagen, N.A.. Breakthrough pain: definition, prevalence and characteristics. Pain, vol.41, no.3, 273-281.

    상세보기

11. Oncology Simmonds MA 1103 13 8 1999 

12. Fine, Perry G, Busch, Michael A. Characterization of Breakthrough Pain by Hospice Patients and Their Caregivers. Journal of pain and symptom management, vol.16, no.3, 179-183.

    상세보기

13. Portenoy RK, Hagen NA: op. cit. 

14. Oncology Patt RB 1035 12 7 1998 

15. 10.1002/1097-0142(19931201)72:11+<3393::AID-CNCR2820721606>3.0.CO;2-O 

    상세보기

16. Glare, P A, Walsh, T D. Dose-ranging study of oxycodone for chronic pain in advanced cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.11, no.5, 973-978.

    상세보기

17. Patt RB: op. cit. 

18. Simmonds MA: op. cit. 

19. Analgesic Ladder for the Management of Cancer Pain Portenoy RK 1995 

20. Cancer Pain Relief World Health Organization 1986 

21. Cherny, Nathan I.. Opioid Analgesics : Comparative Features and Prescribing Guidelines. Drugs, vol.51, no.5, 713-737.

    상세보기

22. Palliative Care Formulary Twycross R 1998 

23. Ripamonti, C, Groff, L, Brunelli, C, Polastri, D, Stavrakis, A, De Conno, F. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.16, no.10, 3216-3221.

    상세보기

24. Zhukovsky, Donna S, Walsh, Declan, Doona, Marie. The Relative Potency between High Dose Oral Oxycodone and Intravenous Morphine : A Case Illustration. Journal of pain and symptom management, vol.18, no.1, 53-55.

    상세보기